Cargando…
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114080/ https://www.ncbi.nlm.nih.gov/pubmed/21687579 http://dx.doi.org/10.1155/2011/820816 |
_version_ | 1782206026278240256 |
---|---|
author | Athanasopoulos, Anastasios Giannitsas, Konstantinos |
author_facet | Athanasopoulos, Anastasios Giannitsas, Konstantinos |
author_sort | Athanasopoulos, Anastasios |
collection | PubMed |
description | Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge. |
format | Online Article Text |
id | pubmed-3114080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31140802011-06-17 An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder Athanasopoulos, Anastasios Giannitsas, Konstantinos Adv Urol Review Article Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge. Hindawi Publishing Corporation 2011 2011-06-07 /pmc/articles/PMC3114080/ /pubmed/21687579 http://dx.doi.org/10.1155/2011/820816 Text en Copyright © 2011 A. Athanasopoulos and K. Giannitsas. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Athanasopoulos, Anastasios Giannitsas, Konstantinos An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title | An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title_full | An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title_fullStr | An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title_full_unstemmed | An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title_short | An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder |
title_sort | overview of the clinical use of antimuscarinics in the treatment of overactive bladder |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114080/ https://www.ncbi.nlm.nih.gov/pubmed/21687579 http://dx.doi.org/10.1155/2011/820816 |
work_keys_str_mv | AT athanasopoulosanastasios anoverviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder AT giannitsaskonstantinos anoverviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder AT athanasopoulosanastasios overviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder AT giannitsaskonstantinos overviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder |